In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Danaher (DHR – Research Report), with a price target of $310.00. Daniel Brennan has given his Buy rating due ...

Dan Brennan, senior analyst at TD Cowen, joins CNBC's 'The Exchange' to discuss his price target on Tempus, AI in diagnostics, and more. Trump backs deployment of European troops in Ukraine after ...

Tech Edge hosted a fireside chat on April 29 at RSAC 2025 in San Francisco with Dan Brennan and Ryan Flanagan, Managing Directors at ICR. The in-person interview was joined by Editor-in-Chief John ...

MARLBOROUGH, Mass., April 23, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that Dan Brennan, executive vice president and chief financial officer, has elected to ...

Analyst Daniel Brennan from TD Cowen maintained a Buy rating on Exact Sciences (EXAS – Research Report) and increased the price target to $86.00 from $82.00. Don't Miss our Black Friday Offers ...

Daniel Brennan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CATALYST PHARMACEUTICALS ...